MedPath

MicroPhage, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA

Terminated
Conditions
Bacteremia
First Posted Date
2012-07-16
Last Posted Date
2013-01-15
Lead Sponsor
MicroPhage, Inc.
Target Recruit Count
764
Registration Number
NCT01640886
Locations
🇺🇸

University of Arizona, Infectious Disease Research, Tuscon, Arizona, United States

🇺🇸

UCLA Clinical Laboratory, Los Angeles, California, United States

🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

Completed
Conditions
Bacteremia
First Posted Date
2010-08-18
Last Posted Date
2010-08-18
Lead Sponsor
MicroPhage, Inc.
Target Recruit Count
1165
Registration Number
NCT01184339

MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial

Completed
Conditions
Bacteremia
Infection
Staphylococcal Infection
Sepsis
First Posted Date
2008-12-24
Last Posted Date
2008-12-24
Lead Sponsor
MicroPhage, Inc.
Target Recruit Count
712
Registration Number
NCT00814151
Locations
🇺🇸

Evanston Northwestern Healthcare Research Institute, Evanston, Illinois, United States

🇺🇸

University of Maryland Baltimore, Baltimore, Maryland, United States

🇺🇸

Johns Hopkins Medical Institute, Baltimore, Maryland, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.